Global Edition
Global Edition
UK Edition
EU Edition
US Edition

Understand the story, not the spin.

Markets

Summit Therapeutics Inc. News

Recent Verilumia coverage about Summit Therapeutics Inc. (SMMT), including reporting-tone insights and market listing information.

FDA declines Summit’s ivonescimab application

FDA declines Summit’s ivonescimab application

The U.S. Food and Drug Administration declined Summit Therapeutics’ application for ivonescimab with chemotherapy for a group of previously treated lung cancer patients, saying the trial did not show a statistically...

Coverage Mix 10 source articles
Left 11% Centre 45% Right 44%
Now playing
0:00 / 0:00